+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Contraceptive Market (2021-2026) by Product Type, Distribution Channel, Application and Geography - Competitive Analysis, Impact of COVID-19, Ansoff Analysis

  • PDF Icon


  • 185 Pages
  • March 2021
  • Region: Global
  • Infogence Global Research
  • ID: 5359447
The Global Contraceptive Market is estimated to be worth USD 56.8Bn in 2020 and is expected to reach USD 144.3 Billion by 2025, growing at a CAGR of 20.5%.

Market Dynamics

The rising prevalence of sexually transmitted diseases, an increasing rate of unintended pregnancies, and increasing awareness of women's reproductive health are the major factors escalating the contraceptive market growth. In addition, legal restrictions on abortion have increased the usage of contraceptives. The increasing population and government initiatives in population have increased demand for contraceptives, which have boosted the market revenue. Companies are using digital platforms to increase their market presence. Growing artificial intelligence in healthcare, companies have developed apps and other mHealth solutions for period tracking and monitor their fertility and prevention.

Stringent government regulation and high time consumption in approval of development and sale of contraceptives are expected to hinder the market growth. Low awareness of contraceptives in emerging countries and side effects associated with contraceptives are further declining the market growth. Active investment of market players in the R&D of contraceptives to expand product lines is anticipated to create lucrative opportunities for the contraceptive market.

Market Segmentation

The Global Contraceptive Market is segmented based on Product Type, Distribution Channel, Application, and Geography.

  • By Product Type, the market is classified as pills, condoms, diaphragms, sponge, vaginal rings, subdermal implants, patches, IUD, injections, and others. Amongst all, the pills segment is estimated to hold the highest market share.
  • By Gender, the market is classified as male and female. Amongst the two, the female segment is estimated to hold the highest market share.
  • By Distribution Channel, the market is classified as healthcare facilities, pharmacies, and others. Amongst all, the pharmacy segment is estimated to hold the highest market share.
  • By Geography, Europe is projected to lead the market.

Recent Developments

  1. Clue gets FDA approval for digital contraceptives. - 8th March 2021
  2. Gedeon Richter PLC acquired rights to market Johnson & Johnson's Evra contraceptive patch assets outside the U.S. - 3rd December 2020

Company Profiles

Some of the companies covered in this report Teva Pharmaceutical Industries Ltd., Merck & Co., Inc., Mayer Laboratories, Inc., Church & Dwight Co., Inc, Reckitt Benckiser Group plc, ORIGIO India Pvt Ltd, Actavis plc, Allergan, Inc., etc

Competitive Quadrant

The report includes the Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.

Why buy this report?

The report offers a comprehensive evaluation of the Global Contraceptive Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.

The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel within the industry.

The report includes an in-depth market analysis using Porter's 5 force model and the Ansoff Matrix. The impact of COVID-19 on the market is also featured in the report.

The report also includes the regulatory scenario of the industry, which will help you make a well-informed decision. The report discusses major regulatory bodies and major rules & regulations imposed on this sector across various geographies.

The report also contains competitive analysis using Positioning Quadrants, the analyst's proprietary competitive positioning tool.

Report Highlights

  • A complete analysis of the market, including parent industry
  • Important market dynamics and trends
  • Market segmentation
  • Historical, current, and projected size of the market based on value and volume
  • Market shares and strategies of key players
  • Recommendations to companies for strengthening their foothold in the market
Frequently Asked Questions about the Global Contraceptive Market

What is the estimated value of the Global Contraceptive Market?

The Global Contraceptive Market was estimated to be valued at $56800 Million in 2021.

What is the growth rate of the Global Contraceptive Market?

The growth rate of the Global Contraceptive Market is 20.5%, with an estimated value of $144300 Million by 2026.

What is the forecasted size of the Global Contraceptive Market?

The Global Contraceptive Market is estimated to be worth $144300 Million by 2026.

Who are the key companies in the Global Contraceptive Market?

Key companies in the Global Contraceptive Market include Actavis plc, Afaxy. Inc., Agile Therapeutics, Allerga. Inc., Ansell Ltd, Apothecus Pharmaceutical Corporation., Bayer AG, BioSante Pharmaceutical. Inc. and Cipla Limited.

Table of Contents

1 Report Description
1.1 Study Objectives
1.2 Market Definition
1.3 Currency
1.4 Years Considered
1.5 Language
1.6 Key Shareholders
2 Research Methodology
2.1 Research Process
2.2 Data Collection and Validation
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Proprietary Models
2.3 Market Size Estimation
2.3.1 Bottom-Up Approach
2.3.2 Top-Down Approach
2.4 Assumptions of the Study
2.5 Limitations of the Study
3 Executive Summary
3.1 Introduction
3.2 Market Size and Segmentation
3.3 Market Outlook
4 Market Influencers
4.1 Drivers
4.1.1 Increasing Rate of Unwanted Pregnancies
4.1.2 Government Initiatives in Population Control
4.1.3 Rising Prevalence of STD
4.2 Restraints
4.2.1 Side Effects Associated with Contraceptives
4.2.2 Stringent Government Regulations
4.3 Opportunities
4.3.1 New Innovative Solutions to Expand the Product Line
4.4 Challenges
4.4.1 Lack of Awareness in Rural Areas
4.4.2 Increasing Infertility Prevalence
4.5 Trends
5 Market Analysis
5.1 Regulatory Scenario
5.2 Porter’s Five Forces Analysis
5.3 Impact of COVID-19
5.4 Ansoff Matrix Analysis
6 Global Contraceptive Market, By Product Type
6.1 Introduction
6.2 Pills
6.3 Condoms
6.4 Diaphragms
6.5 Sponge
6.6 Vaginal Ring
6.7 Subdermal Implants
6.8 Patch
6.9 IUD
6.10 Injections
6.11 Others
7 Global Contraceptive Market, By Gender
7.1 Introduction
7.2 Male
7.3 Female
8 Global Contraceptive Market, By Distribution Channel
8.1 Introduction
8.2 Healthcare Facilities
8.3 Pharmacy
8.4 Others
9 Global Contraceptive Market, By Geography
9.1 Introduction
9.2 North America
9.2.1 US
9.2.2 Canada
9.2.3 Mexico
9.3 South America
9.3.1 Brazil
9.3.2 Argentina
9.3.3 Chile
9.3.4 Colombia
9.4 Europe
9.4.1 UK
9.4.2 France
9.4.3 Germany
9.4.4 Italy
9.4.5 Spain
9.4.6 Netherlands
9.4.7 Sweden
9.4.8 Russia
9.4.9 Rest of Europe
9.5 Asia-Pacific
9.5.1 China
9.5.2 Japan
9.5.3 India
9.5.4 Indonesia
9.5.5 Malaysia
9.5.6 South Korea
9.5.7 Australia
9.5.8 Sri Lanka
9.5.9 Thailand
9.5.10 Rest of APAC
9.6 Middle-East and Africa
9.6.1 Qatar
9.6.2 Saudi Arabia
9.6.3 South Africa
9.6.4 United Arab Emirates
10 Competitive Landscape
10.1 Competitive Quadrant
10.2 Market Share Analysis
10.3 Strategic Initiatives
10.3.1 M&A and Investments
10.3.2 Partnerships and Collaborations
10.3.3 Product Developments and Improvements
11 Company Profiles
11.1 Actavis plc
11.2 Afaxys, Inc.
11.3 Agile Therapeutics
11.4 Allergan, Inc.
11.5 Ansell ltd
11.6 Apothecus Pharmaceutical Corporation.
11.7 Bayer AG
11.8 BioSante Pharmaceuticals, Inc. (
11.9 Church & Dwight Co., Inc
11.10 Cipla Limited
11.11 HLL Lifecare Limited
11.12 Mankind Pharma
11.13 Mayer Laboratories, Inc.
11.14 Merck & Co., Inc.,
11.15 ORIGIO India Pvt Ltd
11.16 Pfizer Inc.
11.17 Reckitt Benckiser Group plc,
11.18 Teva Pharmaceutical Industries Ltd.
11.19 The Cooper Companies, Inc.
11.20 The Female Health Company
11.21 TTK Healthcare Ltd
12 Appendix
12.1 Questionnaire

Companies Mentioned

  • Actavis plc
  • Afaxy. Inc.
  • Agile Therapeutics
  • Allerga. Inc.
  • Ansell Ltd
  • Apothecus Pharmaceutical Corporation.
  • Bayer AG
  • BioSante Pharmaceutical. Inc.
  • Church & Dwight Co. Inc
  • Cipla Limited
  • HLL Lifecare Limited
  • Mankind Pharma
  • Mayer Laboratorie. Inc.
  • Merck & Co. Inc.
  • ORIGIO India Pvt Ltd
  • Pfizer Inc.
  • Reckitt Benckiser Group pl.
  • Teva Pharmaceutical Industries Ltd.
  • The Cooper Companie. Inc.
  • The Female Health Company
  • TTK Healthcare Ltd